0001214659-24-005217.txt : 20240326
0001214659-24-005217.hdr.sgml : 20240326
20240326202852
ACCESSION NUMBER: 0001214659-24-005217
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240323
FILED AS OF DATE: 20240326
DATE AS OF CHANGE: 20240326
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KAZIMI A J
CENTRAL INDEX KEY: 0001075050
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33637
FILM NUMBER: 24785463
MAIL ADDRESS:
STREET 1: 1207 17TH AVENUE SUITE 103
CITY: NASHVILLE
STATE: TN
ZIP: 37212
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CUMBERLAND PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001087294
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2525 WEST END AVENUE
STREET 2: SUITE 950
CITY: NASHVILLE,
STATE: TN
ZIP: 37203
BUSINESS PHONE: 615-255-0068
MAIL ADDRESS:
STREET 1: 2525 WEST END AVENUE
STREET 2: SUITE 950
CITY: NASHVILLE
STATE: TN
ZIP: 37203
4
1
marketforms-65385.xml
PRIMARY DOCUMENT
X0508
4
2024-03-23
0001087294
CUMBERLAND PHARMACEUTICALS INC
CPIX
0001075050
KAZIMI A J
1600 WEST END AVE.
SUITE 1300
NASHVILLE
TN
37203
true
true
true
false
Chairman and CEO
0
Common Stock
2024-03-23
4
F
false
25710
1.81
D
5695557
D
Options (right to buy)
1.88
2024-03-25
4
A
false
100000
0
A
2028-03-25
2029-03-25
Stock Option
100000
368000
D
This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares.
A.J. Kazimi by /s/ John Hamm as attorney-in-fact
2024-03-26